WVU010922: Prospective Evaluation of Xerava (Eravacycline) Prophylaxis in Hematological Malignancy Patients with Prolonged Neutropenia
- Title
- Prospective Evaluation of Xerava (Eravacycline) Prophylaxis in Hematological Malignancy Patients with Prolonged Neutropenia
- Principal Investigator
- Cumpston, Aaron
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Leukemia
- Lymphoma
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Kathryn Oliverio, LPN
- Research Specialist
- Phone: +1 304-293-7374
- Email: kathryn.oliverio1@hsc.wvu.edu